Home > Drug Search >
  • Targets: Transglutaminase 2 (TGM2)
  •   > 
Drug Filter
Status:
NDA Filing (1) Phase Ⅰ (1)
Company:
National Cancer Institute (1) Liaoning Lantian Pharma (1) Dr. Falk (1) Zedira (1)
Indication:
Breast cancer (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Neuroblastoma (1) Malignant glioma (1) Celiac disease (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top